Cronos Group stock reports 58 percent revenue growth
Published on 09/24/2026 at 15:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCronos Group stock is tied to a second-quarter revenue increase of 58 percent to USD 53.0 million in Q2 2026. The company is hosting its first Investor Day on September 24, 2026, at its Kingsville, Ontario facility, with the webcast scheduled for 12:00 p.m. ET.
Revenue reaches USD 53 million
The Globe and Mail reported that Cronos generated USD 53.0 million in net revenue for Q2 2026, up 58 percent from the prior-year quarter. Gross profit climbed to USD 28.5 million, a 96 percent year-over-year increase that lifted gross margin to 54 percent.
The comparison is important because the improvement reached both the top line and gross profit. The company attributed the revenue increase to higher cannabis flower sales in Israel, Canada and Germany, as well as stronger Canadian cannabis extract sales.
Profit replaces prior-year loss
Cronos posted net income of USD 35.7 million in Q2 2026, compared with a net loss of USD 38.5 million in the same period of 2025. Adjusted EBITDA reached USD 13.1 million, versus USD 1.7 million a year earlier, according to The Globe and Mail.
The figures give the Investor Day a clear financial backdrop. Cronos can present operational plans after reporting USD 467.019 million in cash and cash equivalents at June 30, 2026, while operating cash flow for Q2 was USD 24.010 million.
Investor Day adds a near-term checkpoint
According to Cronos, the September 24, 2026 event includes management presentations and a tour of the 1.3 million square foot Cronos GrowCo greenhouse. The company operates cannabis and cannabinoid wellness brands across Canada and international markets, making production capacity and market expansion central topics for investors.
Market value sets the frame
Cronos Group had a market capitalization of USD 1,270,450,933 as of September 24, 2026. Against that valuation, the Q2 revenue of USD 53.0 million and adjusted EBITDA of USD 13.1 million provide the key operating reference points for assessing the company's growth profile.
Cronos Group key data
- Company: Cronos Group Inc.
- Ticker: CRON
- Trading venue: TSX
- Market capitalization: USD 1,270,450,933 (as of September 24, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
